“…Downregulation of the receptors for EGF (Honneger et al, 1987;Glenney et al, 1988), insulin (Russell et al, 1987;McClain et al, 1987;Hari and Roth, 1987), M-CSF (Downing et al, 1989;Carlberg et al, 1991) and PDGF (Sorkin et al, 1991) is thought to be dependent upon intrinsic receptor tyrosine kinase activity, largely because both processes are inhibited by mutation of an invariant lysine residue of the b3 strand ( Figure 1a). In support of this, multiple mutations of tyrosine autophosphorylation sites within the carboxyl terminus of the EGF receptor also inhibit downregulation (Sorkin et al, 1992) as do mutations of autophosphorylation sites within the activating loop of the kinase domain of the insulin receptor (Carpentier, 1994).…”